review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1052829483 |
P356 | DOI | 10.1111/1523-1747.EP12541374 |
P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S0022202X15456556?httpAccept=text/plain |
https://api.elsevier.com/content/article/PII:S0022202X15456556?httpAccept=text/xml | ||
P698 | PubMed publication ID | 390059 |
P5875 | ResearchGate publication ID | 22751775 |
P2093 | author name string | W. R. Gammon | |
P2860 | cites work | Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes | Q28269696 |
Complement-derived leukotactic factors in inflammatory synovial fluids of humans | Q34058258 | ||
Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis | Q34067442 | ||
A Familial Deficiency of the Phagocytosis-Enhancing Activity of Serum Related to a Dysfunction of the Fifth Component of Complement (C5) | Q59286831 | ||
Homozygous deficiency of C3 in a patient with repeated infections | Q59461756 | ||
Leucocyte movement and colchicine treatment in Behcet's disease | Q66699464 | ||
Effects of Corticosteroid Therapy on Human Monocyte Function | Q66891694 | ||
Plasma and cell-derived inhibitors of human neutrophil chemotaxis | Q66899704 | ||
Neutrophil Chemotaxis in Patients With Atopic Dermatitis Without Infection | Q67324251 | ||
Hyperimmunoglobulin E Syndrome | Q67324306 | ||
Griseofulvin Inhibition of Polymorphonuclear Leucocyte Chemotaxis in Boyden Chambers | Q67332067 | ||
Incontinentia Pigmenti and Defective Neutrophil Chemotaxis | Q67348113 | ||
Inflammatory and immune cell function in psoriasis--a subtle disorder I. In vivo and in vitro survey | Q67379100 | ||
Activation of the alternative (properdin) pathway of complement by Candida albicans and related species | Q67498921 | ||
Leucocyte chemotactic factor generated by tryptic digestion of human IgM | Q67523945 | ||
Functional capabilities of steroid-recruited neutrophils harvested for clinical transfusion | Q67687688 | ||
Proteinases of human epidermis; a possible mechanism for polymorphonuclear leukocyte chemotaxis | Q68229660 | ||
Locomotion of human polymorphonuclear leucocytes | Q69183594 | ||
Defective Neutrophil Chemotaxis and Cellular Immunity in a Child with Recurrent Infections | Q69248052 | ||
Effects of cytochalasin B on polymorphonuclear leucocyte locomotion, phagocytosis and glycolysis | Q70439654 | ||
Human polymorphonuclear leukocytes: demonstration of microtubules and effect of colchicine | Q72212864 | ||
Defective granulocyte chemotaxis in the Chediak-Higashi syndrome | Q34067942 | ||
Activation and control mechanisms of Hageman factor-dependent pathways of coagulation, fibrinolysis, and kinin generation and their contribution to the inflammatory response | Q34080346 | ||
Demonstration of a receptor on rabbit neutrophils for chemotactic peptides | Q34353823 | ||
Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function. | Q34460377 | ||
Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors | Q34462259 | ||
Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome | Q34465607 | ||
Interaction of leukocyte chemotactic factors with the cell surface. I. Chemotactic factor-induced changes in human granulocyte surface charge | Q34478124 | ||
Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies | Q35202075 | ||
Regulatory dysfunction in leukotaxis | Q36077739 | ||
The regulatory role of divalent cations in human granulocyte chemotaxis. Evidence for an association between calcium exchanges and microtubule assembly | Q36196127 | ||
The in vitro action of hydrocortisone on leucocyte migration | Q36263664 | ||
The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase | Q36269067 | ||
The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats | Q36270882 | ||
Leukotactic factors elaborated by virus-infected tissues | Q36270966 | ||
Platelet-dependent generation of chemotactic activity in serum | Q36272285 | ||
The chemosuppression of chemotaxis | Q36334629 | ||
The Diversity Of Mast Cell-Derived Mediators: Implications For Acute, Subacute, And Chronic Cutaneous Inflammatory Disorders | Q39400385 | ||
Biology of leukotaxis | Q39618276 | ||
Complement deficiency states | Q39711128 | ||
Chemotaxis in cutaneous disease | Q39723522 | ||
Modulation of human neutrophil chemotactic responses by cyclic 3′,5′-guanosine monophosphate and cyclic 3′,5′-adenosine monophosphate | Q39929248 | ||
Mediators Of Cellular Immunity, Their Nature And Assay | Q40015690 | ||
Correction of Leukocyte Function in Chediak-Higashi Syndrome by Ascorbate | Q40016540 | ||
Enhanced Chemotactic and Phagocytic Activities of Leukocytes in Psoriasis Vulgaris | Q40171778 | ||
Lazy-leucocyte syndrome. A new disorder of neutrophil function | Q40926429 | ||
The role of cytoplasmic microtubules in polymorphonuclea leukocyte chemotaxis. Evidence for the release hypothesis by means of time-lapse analysis of PMN movement relative to dot-like attractants | Q41077907 | ||
The effect of immunosuppressive and anti-inflammatory drugs on monocyte function in vitro | Q41929911 | ||
THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO | Q42001631 | ||
A new familial defect of neutrophil movement | Q43471331 | ||
Atopic dermatitis and impaired neutrophil chemotaxis in Job's syndrome | Q43613534 | ||
The effect of antimicrobial agents on leukocyte chemotaxis | Q43776555 | ||
Defective neutrophil chemotaxis and hyperimmunoglobulinemia E-a reversible defect? | Q44021770 | ||
Leukotactic dystunction in sarcoidosis | Q44257076 | ||
Defective neutrophil chemotaxis with variant ichthyosis, hyperimmunoglobulinemia E, and recurrent infections | Q44301764 | ||
Familial Neutrophil Chemotaxis Defect, Recurrent Bacterial Infections, Mucocutaneous Candidiasis, and Hyperimmunoglobulinemia E | Q44469860 | ||
Zinc correction of defective chemotaxis in acrodermatitis enteropathica | Q44684696 | ||
Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent "cold" staphylococcal abscesses | Q44700147 | ||
Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections | Q44806967 | ||
Incontinentia pigmenti. Evidence for both neutrophil and lymphocyte dysfunction | Q44879033 | ||
The difference between random movement and chemotaxis. Effects of antitubulins on neutrophil granulocyte locomotion. | Q53993543 | ||
Neutrophil Actin Dysfunction and Abnormal Neutrophil Behavior | Q54469619 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | biochemistry | Q7094 |
cell biology | Q7141 | ||
dermatology | Q171171 | ||
chemotaxis | Q658145 | ||
P304 | page(s) | 515-520 | |
P577 | publication date | 1979-12-01 | |
P1433 | published in | Journal of Investigative Dermatology | Q3186921 |
P1476 | title | Phagocyte Chemotaxis | |
P478 | volume | 73 |
Q61632990 | Human hyper-IgE syndrome: singular or plural? | cites work | P2860 |
Search more.